Schläpfer, A. (2020) “The ’Holy Grail’ in Immuno-Oncology: AC BioScience SA is Aiming to Potentiate Anti-PD-1 Therapy Efficacy through Tumor Cell Conditioning Strategy”, CHIMIA, 74(10), p. 771. doi: 10.2533/chimia.2020.771.